Skip to main content
Top
Published in: Supportive Care in Cancer 5/2013

01-05-2013 | Short Communication

Validation of the Chinese version of the Resilience Scale and its cutoff score for detecting low resilience in Chinese cancer patients

Authors: Jun Tian, Jin Sheng Hong

Published in: Supportive Care in Cancer | Issue 5/2013

Login to get access

Abstract

Purpose

We aim to investigate the reliability and validity of the Chinese version of the Resilience Scale (RS-14) and to determine the cutoff score of the RS-14 for screening Chinese cancer patients with low resilience.

Methods

The current study was divided into two studies. In the first study, we randomly selected 625 people and obtained their scores in the Chinese version of the RS-14 and SF-36 using cross-sectional survey. We then calculated the validity and reliability of the Chinese version of the RS-14. In the second study, we selected 970 hospital cancer patients diagnosed during 2010 to 2011 and assessed for their resilience once and for anxiety, depression, and quality of life on two occasions. We determined the cutoff score of the RS-14 based on the maximum Youden Index, with the scores of anxiety and depression as gold standards.

Results

The correlation coefficients for inter-items were in the range of 0.23 to 0.68 (P < 0.001), whereas those for the item–scale were in the range of 0.62 to 0.82 (P < 0.001). Two factors represent the factor structure of the RS-14. The correlation coefficient between the RS-14 and SF-36 scores was 0.82 (P < 0.001). The split-half reliability and test–retest reliability of the RS-14 were both 0.82 (P < 0.001), and the internal consistency Cronbach's α was 0.93. The cutoff score of 64 was obtained for screening cancer patients with low resilience (sensitivity and specificity were 0.74 and 0.71, respectively).

Conclusion

The Chinese version of the RS-14 has good validity and reliability, and it can measure the resilience of Chinese people. The cutoff score of 64 for the RS-14 is appropriate for detecting cancer patients with low resilience in order to decrease psychological stress and improving quality of life. Health care nurses can screen and detect cancer patients with low resilience based on the said cutoff score to timely provide psychological care and interventions for the patients.
Literature
2.
go back to reference Efficace F, Bottomley A, van Andel G (2003) Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 97:377–388PubMedCrossRef Efficace F, Bottomley A, van Andel G (2003) Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 97:377–388PubMedCrossRef
3.
go back to reference Lawford J, Eiser C (2001) Exploring links between the concepts of quality of life and resilience. Pediatr Rehab 4(4):209–216 Lawford J, Eiser C (2001) Exploring links between the concepts of quality of life and resilience. Pediatr Rehab 4(4):209–216
4.
5.
go back to reference Yi JP, Smith RE, Vitaliano PP (2005) Stress-resilience, illness, and coping: a person-focused investigation of young women athletes. J Behav Med 28(3):257–265PubMedCrossRef Yi JP, Smith RE, Vitaliano PP (2005) Stress-resilience, illness, and coping: a person-focused investigation of young women athletes. J Behav Med 28(3):257–265PubMedCrossRef
6.
go back to reference Xi JZ, Sang B (2002) A general review of the studies of the resilience. Health Psychol J 10(4):314–318 Xi JZ, Sang B (2002) A general review of the studies of the resilience. Health Psychol J 10(4):314–318
7.
go back to reference Bowen DJ, Morasca AA, Meischke H et al (2003) Measures and correlates of resilience. Women Health 38:65–76PubMedCrossRef Bowen DJ, Morasca AA, Meischke H et al (2003) Measures and correlates of resilience. Women Health 38:65–76PubMedCrossRef
8.
go back to reference Strauss B, Brix C, Fischer S et al (2007) The influence of resilience on fatigue in cancer patients undergoing radiation therapy. J Cancer Res Clin Oncol 133:511–518PubMedCrossRef Strauss B, Brix C, Fischer S et al (2007) The influence of resilience on fatigue in cancer patients undergoing radiation therapy. J Cancer Res Clin Oncol 133:511–518PubMedCrossRef
9.
go back to reference Wk H, Law CC, Yin J, Fu YT (2010) Resource loss, resource gain, and psychological resilience and dysfunction following cancer diagnosis: a growth mixture modeling approach. Health Psychol 29(5):484–495CrossRef Wk H, Law CC, Yin J, Fu YT (2010) Resource loss, resource gain, and psychological resilience and dysfunction following cancer diagnosis: a growth mixture modeling approach. Health Psychol 29(5):484–495CrossRef
10.
go back to reference Wagnild GM, Young HM (1993) Development and psychometric evaluation of the Resilience Scale. J Nurs Meas 1(2):165–178PubMed Wagnild GM, Young HM (1993) Development and psychometric evaluation of the Resilience Scale. J Nurs Meas 1(2):165–178PubMed
11.
go back to reference Ahern NR, Kiehl EM, Sole ML, Byers J (2006) A review of instruments measuring resilience. Issues in Compr Nurs 29(2):103–125CrossRef Ahern NR, Kiehl EM, Sole ML, Byers J (2006) A review of instruments measuring resilience. Issues in Compr Nurs 29(2):103–125CrossRef
12.
go back to reference Wagnild GM (2009) The Resilience Scale user's guide for the US English version of the Resilience Scale and the 14-item Reselience Scale (RS-14). The Resilience Center, Montana Wagnild GM (2009) The Resilience Scale user's guide for the US English version of the Resilience Scale and the 14-item Reselience Scale (RS-14). The Resilience Center, Montana
13.
go back to reference Bai GT, Ma YW, Jiang L (2009) A recent progress of the SF-36 in the world. J Clin Res 26(12):2367–2369 Bai GT, Ma YW, Jiang L (2009) A recent progress of the SF-36 in the world. J Clin Res 26(12):2367–2369
14.
go back to reference Zhen LC, Tian HR, Xie PZ (2000) Medical quality of survival evaluation. Junshi Yixue Kexue, Beijing Zhen LC, Tian HR, Xie PZ (2000) Medical quality of survival evaluation. Junshi Yixue Kexue, Beijing
15.
go back to reference Zigmond AS, Snaith PR (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef Zigmond AS, Snaith PR (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef
16.
go back to reference Leung CM, Ho S, Kan CS, Hung CH, Chen CN (1993) Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J psychsom 40:29–34 Leung CM, Ho S, Kan CS, Hung CH, Chen CN (1993) Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J psychsom 40:29–34
19.
go back to reference Damásio BF, Borsa JC (2011) 14-item Resilience Scale (RS-14): psychometric properties of the Brazilian version. J Nurs Meas 19(3):131–145PubMedCrossRef Damásio BF, Borsa JC (2011) 14-item Resilience Scale (RS-14): psychometric properties of the Brazilian version. J Nurs Meas 19(3):131–145PubMedCrossRef
20.
go back to reference Nishi D, Uehara R, Kondo M, Matsuoka Y (2010) Reliability and validity of the Japanese version of the Resilience Scale and its short version. BMC Res Notes 3:310PubMedCrossRef Nishi D, Uehara R, Kondo M, Matsuoka Y (2010) Reliability and validity of the Japanese version of the Resilience Scale and its short version. BMC Res Notes 3:310PubMedCrossRef
Metadata
Title
Validation of the Chinese version of the Resilience Scale and its cutoff score for detecting low resilience in Chinese cancer patients
Authors
Jun Tian
Jin Sheng Hong
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1699-x

Other articles of this Issue 5/2013

Supportive Care in Cancer 5/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine